Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1997-11-05
1999-10-05
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
424655, 424681, 424682, 514165, A61K 3326, A61K 3324, A61K 3314, A61K 3306, A61K 3160
Patent
active
059620307
ABSTRACT:
A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
REFERENCES:
patent: Re33988 (1992-07-01), Evans
patent: 5045316 (1991-09-01), Kaplan
patent: 5069913 (1991-12-01), Posner et al.
patent: 5087623 (1992-02-01), Boynton et al.
patent: 5087624 (1992-02-01), Boynton et al.
patent: 5164384 (1992-11-01), Paul
patent: 5527790 (1996-06-01), McNeill et al.
patent: 5543405 (1996-08-01), Keown
patent: 5550113 (1996-08-01), Mann
patent: 5614224 (1997-03-01), Womack
patent: 5620967 (1997-04-01), McNeill et al.
patent: 5665385 (1997-09-01), Johnson et al.
patent: 5770215 (1998-06-01), Moshyedi
patent: 5789401 (1998-08-01), McCarty
Abbott, et al., "The Impact of Diabetes on Survival Following Myocardial Infarction in Men vs Women" JAMA 260 (23):3456-3460 (1988).
ACC/AHA Task Force Report, "Guidelines for the Early Management of Patients With Acute Myocardial Infarction; A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients With Acute Myocardial Infarction)" JACC 16 (2):249-292 (1990).
Anderson and Kozlovsky, "Chromium intake, absorption and excretion of subjects consuming self-selected diets" The American Journal of Clinical Nutrition 41:1177-1183 (1985).
Anderson, et al., "Urinary chromium excretion and insulinogenic properties of carbohydrates" Am J Clin Nutr 51:864-868 (1990).
Antiplatelet Trialists' Collaboration, "Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patienst" BMJ308:81-106 (1994).
Arsenian, M. A., "Magnesium and Cardiovascular Disease" Progress in Cardiovascular Diseases 35 (4):271-310 (1993).
Arsenian, M. A., "Magnesium and the Autonomic Nervous System" Magnesium and Cardiovascular Disease 291-310 (1993).
Avins, "Lowering Risk without Lowering Cholesterol: Implications for National Cholesterol Policy" Annals of Internal Medicine 125 (6):502-506 (1996).
Bailey, C. J, "Biguanides and NIDDM" Diabetes Care 15 (6):755-772 (1992).
Barnard, et al., "Diet and Exercise in the Treatment of NIDDM; The need for early emphasis" Diabetes Care 17 (12):1469-1472 (1994).
Bierman, E. L., "Atherogenesis in Diabetes" Arteriosclerosis and Thrombosis 12 (6):647-656 (1992).
Bloomgarden, Z. T., "American Diabetes Association Scientific Sessions, 1995; Magnesium Deficiency, Atheroslerosis, and Health Care" Diabetes Care 18 (12):1624-11627 (1995).
Caballero, "Vitamin E Improves the Action of Insulin" Nutrition Reviews 51 (11):339-340 (1993).
Cam, et al., "Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats" Diabetologia 36:218-224 (1993).
Clarke, R. J., "Suppression of Thromboxane A.sub.2 But Not of Systemic Prostacyclin by Controlled-Release Aspirin" The New England Journal of Medicine 325 (16):1137-1141 (1991).
Classen, H. G., "Magnesium and Potassium Deprivation and Supplementation in Animals and Man: Aspects in View of Intestinal Absorption" Magnesium 3:257-264 (1984).
Cohen and Kitzes, "Magnesium Sulfate and Digitalis-Toxic Arrhythmias" JAMA 249 (20):2808-2810 (1983).
Cohen, et al., "Oral Vanadyl Sulfate Improves Hepatic and Peripheral Insulin Sensitivity in Patients with Non-Insulin-dependent Diabetes Mellitus" J. Clin. Invest. 95:2501-2509 (1995).
Colwell, et al., "Correlation of Platelet Aggregation, Plasma Factor Activity, and Megathrombocytes in Diabetic Subjects With and Without Vascular Disease" Metabolism 26 (3):279-285 (1977).
Dai, et al., "One-year Treatment of Streptozotocin-Induced Diabetic Rats with Vanadyl Sulphate" Pharmacology & Toxicology 74:101-109 (1994).
Davi, et al., "Thromboxane B.sub.2 Formation and Platelet Sensitivity to Prostacyclin in Insulin-Dependent and Insulin-Independent Diabetics" Thrombosis Research 26:359-370 (1982).
Davi, et al., "Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus" The New England Journal of Medicine 322 (25):1769-1774 (1990).
Davies, et al., "Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death" Circulation 73 (3):418-427 (1986).
Davies, et al., "Monotherapy With Magnesium Increases Abnormally Low High Density Lipoprotein Cholesterol: A Clinical Assay" Current Therapeutic Research 36 (2):341-346 (1984).
De Tata, et al., "Beneficial Effects of the Oral Administration of Vanadyl Sulphate on Glucose Metabolism in Senescent Rats" Journal of Gerontology 48 (5):B191-B195 (1993).
Defronzo and Ferrannini, "Insulin Resistance; A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease" Diabetes Care 14 (3):173-194 (1991).
Dieber-Rotheneder, et al., "Effect of oral supplementation with D-.alpha.-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation" Journal of Lipid Research 32:1325-1332 (1991).
Donadio, et al., "Platelet-Inhibitor Treatment of Diabetic Nephropathy: A 10-Year Prospective Study" Mayo Clin Proc 63:3-15 (1988).
Dubyak and Kleinzeller, "The Insulin-mimetic Effects of Vanadate in Isolated Rat Adipocytes" The Journal of Biological Chemistry 255 (11):5306-5312 (1980).
ETDRS Investigators, "Aspirin Effects on Mortality and Morbid in Patients With Diabetes Mellitus" JAMA 268 (10):1292-1300 (1992).
Ewald, et al., "Hypomagnesemia in Diabetic Children" Acta Padiatr Scand 72:367-371 (1983).
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)" JAMA 269 (23):3015-3023 (1993).
Franz, et al., "Nutrition Principles for the Management of Diabetes and Related Complications" Diabetes Care 17 (5):490-518 (1994).
Freund, et al., "Chromium Deficiency During Total Parenteral Nutrition" JAMA 241 (5):496-498 (1979).
Gunnar et al., "Recommendations for Angioplasty After Intravenous Thrombolysis" JAAC 16 (2):249-292 (1990).
Haffner, et al., "Cardiovascular Risk Factors in Confirmed Prediabetic Individuals; Does the Clock for Heart Disease Start Ticking Before the Onset of Clinical Diabetes?" JAMA 263 (21):2893-2898 (1990).
Haffner, et al., "Prospective Analysis of the Insulin-Resistance Syndrome (Syndrome X)" Diabetes 41:715-722 (1992).
Halberstam, et al., "Oral Vanadyl Sulfate Improves Insulin Sensitivity in NIDDM but Not in Obese Nondiabetic Subjects" Diabetes 45:659-666 (1996).
Harris, et al., "Onset of NIDDM Occurs at Least 4-7 Yr Before Clinical Diagnosis" Diabetes Care 15 (7):815-819 (1992).
Hatwal, et al., "Association of hypomagnesemia with diabetic retinopathy" Acta Ophthalmologica 67:714-716 (1989).
Heath, et al., "Platelet Adhesiveness and Aggregation in Relation to Diabetic Retinopathy" Diabetologia 7:308-315 (1971).
Hennekens, et al., "An Overview of the British and American Aspirin Studies" The New England Journal of Medicine 318 (14):923-924 (1988).
Hirsh, et al., "Aspirin and Other Platelet-Active Drugs; The Relationship Among Dose, Effectiveness, and Side Effects" Chest 108 (4):247S 257S (1995).
Jain, et al., "Some Metabolic Facets of Magnesium in Diabetes Mellitus" Jr. Asso. Phys. Ind 24:827-831 (1976).
Jarrett, et al., "The Bedford Survey: Ten Year Mortality Rates in Newly Diagnosed Diabetics, Borderline Diabetics and Normoglycaemic Controls and Risk Indices for Coronary Heart Disease in Borderline Diabetics" Diabetologia 22:79-84 (1982).
Jeejeebhoy, "Chromium deficiency, glucose intolerence, and ne
Akesis Pharmaceuticals, Inc.
Jarvis William R. A.
Reiter Stephen E.
LandOfFree
Dietary supplement and method of treatment for diabetic control does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dietary supplement and method of treatment for diabetic control, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplement and method of treatment for diabetic control will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168726